Reporting of suspected adverse reactionsReporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.
|Minimum Order Quantity||3000 Litre|
|Product Type||Finished Product|
|1 Box Contain (Bottle)||12|
|Quantity Per Pack||1000 ml|